Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity-Reference-Cited by-同舟云学术

Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity

Published:2007-07 Issue:7 Volume:34 Page:419-429
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

YAMAMOTO Aisaku,WATANABE Hideaki,SUEKI Hirohiko,NAKANISHI Takako,YASUHARA Hajime,IIJIMA Masafumi

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1346-8138.2007.00304.x/fullpdf

Reference52 articles.

1. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.

2. The Interaction between Langerhans Cells and CD4+T Cells

3. Review: Contact Hypersensitivity: The Mechanism of Immune Responses and T Cell Balance

4. Skin Inflammation During Contact Hypersensitivity Is Mediated by Early Recruitment of CD8+ T Cytotoxic 1 Cells Inducing Keratinocyte Apoptosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The omega-3 postbiotic trans-10-cis-15-octadecadienoic acid attenuates contact hypersensitivity in mice through downregulation of vascular endothelial growth factor A;Frontiers in Cellular and Infection Microbiology;2024-05-22

2. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis;European Journal of Pharmacology;2016-11

3. Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles;Frontiers in Immunology;2015-11-06

4. Angiogenesis and lymphangiogenesis in inflammatory skin disorders;Journal of the American Academy of Dermatology;2015-07

5. Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions;CNS & Neurological Disorders - Drug Targets;2008-10-01